ID BP000003 Classic;
DT DD-MMM-YYYY
DE PropFunc=Oxidoreductases > Acting on the CH-OH group of donors > With
DE NAD+ or NADP+
DE as acceptor;
DE PropEC=1.1.1.-;
DE E-value=3e-67;
AC P0CH36, P9WQC5, P75691, A0A059C2G1, A0A059C2H4, D7TVV9, A0A059C2G9,
AC A0A059C336, A0A058ZVP2, A0A059C2G5, A0A059C3Y9, A0A059C333, Q2KNL5, P48523,
AC O49482, Q6ZHS4;
EC 1.1.1.195 (13), 1.1.1.2 (3);
BP std complexity=0.642576 324-333 AA;
A-x(6)-L-x(5)-[ST]-x-R-x(2)-G-x(2)-D-V-x(3)-[IV]-x(3)-G-[IV]-C-[HY]-[AST]-D-
[ILV]-x(3)-[KR]-x(7)-Y-P-x-V-P-G-H-E-[IV]-x-G-x-V-x(2)-V-G-x(2)-V-x-[KR]-
[FY]-x(2)-G-D-x-V-G-V-G-x(2)-V-x(2)-C-x(2)-C-x(2)-C-x(3)-[ILV]-E-x(2)-C-
x(5,7)-[ST]-[FY]-[DN]-x(4)-[DN]-x(3,4)-T-x-G(2)-[FY]-[AS]-x(3)-[IV]-[IV]-x-
[EQ]-x-[FY]-x(2)-[KR]-I-x(9,10)-A-P-L(2)-C-A-G-[ILV]-T-x-Y-[ST]-P-[LM]-x-
[HR]-x(10,11)-[IV]-[ILV]-G-[IL]-G(2)-[LV]-G-H-[LMV]-x-[IV]-K-x(3)-[AS]-[FM]-
G-x(2)-V-x(2)-[FIL]-[ST]-x-S-x(2)-K-x(6,7)-L-G-A-x(7)-[DN]-x(3)-[FM]-x(6)-
[FL]-D-x-[IV]-[IL]-[DN]-T-x(6)-[FL]-x(2)-[FY]-x(3)-L-x(3)-G-x-[LM]-x(2)-
[LMV]-G-x(10,13)-[ILV]-x(4)-[KR]-x-[ILV]-[AST]-G-S-x(2)-G-x(3)-[DEN]-x(2)-E-
[MV]-[IL]-x-[FL]-C-x(2)-[HKQ]-x-[ILV]-x(3)-I-E-x-[IV]-x(2)-[DQ]-x(13)-[LV]
BP ext complexity=0.355303 324-333 AA;
A-x(6)-L-x(5)-[ST]-x-R-x(2)-G-x(2)-D-V-x(3)-[IV]-x(3)-G-[IV]-C-[HY]-[AST]-D-
[ILV]-x(3)-[KR]-x(7)-Y-P-x-V-P-G-H-E-[IV]-x-G-x-V-x(2)-V-G-x(2)-V-x-[KR]-
[FY]-x(2)-G-D-x-V-G-V-G-x(2)-V-x(2)-C-x(2)-C-x(2)-C-x(3)-[ILV]-E-x(2)-C-
x(5,7)-[ST]-[FY]-[DN]-x(4)-[DN]-x(3,4)-T-x-G(2)-[FY]-[AS]-x(3)-[IV]-[IV]-x-
[EQ]-x-[FY]-x(2)-[KR]-I-x(9,10)-A-P-L(2)-C-A-G-[ILV]-T-x-Y-[ST]-P-[LM]-x-
[HKQR]-x(10,11)-[IV]-[ILV]-G-[IL]-G(2)-[ILV]-G-H-[ILMV]-x-[IV]-K-x(3)-[AS]-
[FLM]-G-x(2)-V-x(2)-[FILM]-[ST]-x-S-x(2)-K-x(6,7)-L-G-A-x(7)-[DN]-x(3)-
[FLM]-x(6)-[FL]-D-x-[IV]-[IL]-[DN]-T-x(6)-[FL]-x(2)-[FY]-x(3)-L-x(3)-G-x-
[LM]-x(2)-[ILMV]-G-x(10,13)-[ILV]-x(4)-[KR]-x-[ILV]-[AST]-G-S-x(2)-G-x(3)-
[DEN]-x(2)-E-[ILMV]-[IL]-x-[FL]-C-x(2)-[HKNQR]-x-[ILV]-x(3)-I-E-x-[IV]-x(2)-
[DEQ]-x(13)-[ILV]
//